Initial and steady-state pharmacokinetics of a vaginally administered formulation of progesterone
- 31 August 1995
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 173 (2), 471-478
- https://doi.org/10.1016/0002-9378(95)90268-6
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Progesterone-releasing vaginal rings for use in postpartum contraception. II. Pharmacokinetic profiles in womenContraception, 1992
- Progesterone-releasing vaginal rings for use in postpartum contraception. I. In vitro release rates of progesterone from core-loaded ringsContraception, 1992
- Sedative and hypnotic effects of oral administration of micronized progesterone may be mediated through its metabolitesAmerican Journal of Obstetrics and Gynecology, 1988
- Comparison of serum progesterone levels in dogs after administration of progesterone by vaginal tablet and vaginal suppositoriesAmerican Journal of Obstetrics and Gynecology, 1987
- New developmemts in oral, injectable and implantable contraceptives, vaginal rings and intrauterine devices A reviewContraception, 1986
- Fertility regulation in nursing women: VIII. Progesterone plasma levels and contraceptive efficacy of a progesterone-releasing vaginal ringContraception, 1985
- Effect of the suppository base on progesterone delivery from the vaginaFertility and Sterility, 1983
- Intravaginal administration of progesterone: enhanced absorption after estrogen treatmentFertility and Sterility, 1981
- Absorption and metabolism of oral progesterone.BMJ, 1980
- Vaginal Progesterone for ContraceptionFertility and Sterility, 1978